Cornell Researchers Identify A Weak Link In Cancer Cell Armor
Posted on: Thursday, 12 November 2009, 22:38 CST
The seeming invincibility of cancerous tumors may be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain cells to repair themselves. Researchers at the Cornell University College of Veterinary Medicine have discovered that inactivation of a DNA repair gene called Hus1 efficiently kills cells lacking p53 -- a gene mutated in the majority of human cancers.
Using a mouse model, senior author Robert Weiss, associate professor of molecular genetics, first author and graduate student Stephanie Yazinski and colleagues explored how cells respond when both genes are inhibited. When they inactivated the Hus1 gene in healthy mammary gland tissues, the researchers report, it caused genome damage and cell death. And when they studied the effects of Hus1 inactivation in p53-deficient cells, which are highly resistant to cell death, they discovered that the ability of Hus1 inactivation to kill cells was even greater.
The study is published in the Proceedings of the National Academy of Sciences (Nov. 9).
"Our work contributes to an important new understanding of cancer cells and their weaknesses," Weiss said. "The mutations that allow cancer cells to divide uncontrollably also make the cancer cells more dependent on certain cellular processes. We were able to exploit one such dependency of p53-deficient cells and could efficiently kill these cells by inhibiting Hus1."
Weiss and his team have new experiments under way. "We've proven the power of inhibiting both pathways in normal tissue," said Weiss. "Now we want to extend our knowledge to cancerous tissue and determine if the loss of Hus1 will impact the ability of cancers with p53 mutations to take hold and grow."
---
On the Net:
Related Articles
- The Cancer Cure Coalition Supports the Nomination of Dr. Andrew Von Eschenbach As Commissioner of the U.S. FDA and Calls for the Approval of Advexin, a New Gene Therapy Treatment for Cancer
- Green Tea Polyphenol Epigallocatechin-3 Gallate (EGCG) Affects Gene Expression of Breast Cancer Cells Transformed By the Carcinogen 7,12- Dimethylbenz[a]Anthracene1-3
- Genes Linked to Prostate Cancer
- Turned-Off Genes Linked to Ovarian Cancer
- APC, K-Ras, and P53 Gene Mutations in Colorectal Cancer Patients: Correlation to Clinicopathologic Features and Postoperative Surveillance
- GenoMed Finds Two Genes Linked to Common Cancers
- University of Pittsburgh; A cell-mediated approach to sFlt-1 gene therapy targets thyroid cancer
- Follicular Thyroid Carcinoma; A cell-mediated approach to sFlt-1 gene therapy targets thyroid cancer
- Seoul National University; The additive effects of TRAIL and p53 gene therapy diminish cancer cell growth
- Pulmonary Medicine; The additive effects of TRAIL and p53 gene therapy diminish cancer cell growth
 |
 |
User Comments (0)
RSS Feeds